Introducing a Step Challenge
Adam Martin discusses how to implement a step challenge for pharmacy employees.
Related Articles
Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC
As of May 2024, follow-up and exploratory analyses of MARIPOSA show improvements in outcomes for patients with EGRF-mutated non–small cell lung cancer (NSCLC).
From Opioids to Cannabis: The Impact of Cannabis Rescheduling on Pharmacy Revenue Streams
The DEA will have a hearing in December 2024 regarding the potential reclassification of cannabis to Schedule III, which could significantly impact the regulatory environment…
Cutting-Edge Targeted, Cytotoxic, and Immunologic Therapies Form Next Generation of mNSCLC Treatments
Highlights from multiple trials investigating novel treatments for mNSCLC were presented at 2024 World Conference on Lung Cancer.
Advances With Various Therapies Targeting DLL3 in Lung Neuroendocrine Tumors
An overview of the latest developments in targeting DLL3 in lung neuroendocrine tumors were presented at the 2024 World Conference on Lung Cancer.
Local Therapy Developments Hold Promise for Survival Improvements for NSCLC
In a session at the 2024 World Conference on Lung Cancer, presenters highlight the most significant developments in local therapy for metastatic non–small cell lung…
FDA Grants Orphan Drug Designation to AISA-021 for Systemic Sclerosis
The company also submitted data from the ongoing phase 2 study, demonstrating the improvements of the investigational drug for symptoms of overall disease severity.
VLA1553 Chikungunya Virus Vaccine Shows Antibody Persistence Up to 2 Years Following Administration
The investigators of the phase 3b trial (NCT04838444) will continue to follow up with patients for up to 10 years.
Patients With Difficult-To-Treat Asthma Require Different Intervention Methods Based on Comorbidities
To help with treatment response and compliance as well as optimize treatment, communication between patients and health care providers is necessary.
IVIG Associated With Shorter Hospital, ICU Length of Stay in Immunocompromised Patients With Respiratory Infections
When IVIG was administered within 48 hours of hospital admission, hospital and ICU length of stay were dramatically shortened.
Impact of Value-Based Care in Oncology: Insights from COA 2024
Lalan Wilfong, MD, discusses the road to value-based care and payment reform in cancer care.